JAMAICAPHARMACEUTICALMARKET ANALYSIS

Presented byRaphael D. Barrett

Analysis is provided for all Active Pharmaceutical Ingredients (API) and Illnesses covered by the NHFcard programme

The NHFcard covers 15 CNCD with just under 200 API in 1,000 presentations

In 2007 & 2008, NHFcard benefits accounted for 55% of the total prescription drugs market in Jamaica

For the API covered by the NHFcard, it is estimated that utilisation of these benefits typically account for 75% of their market

In 2007 & 2008, 90% of NHFcard benefits were accessed through private pharmacies

The analysis offered presents a direct reading on two-thirds of the market for the Active Pharmaceutical

Ingredient

Reports

Three types of reports are offered: Active Pharmaceutical Ingredient Therapeutic analysis Market analysis

Analysis is based on activity in the private retail pharmaciesData is available for the public sector – Drug Serv and RHA pharmacies

API Reports

Provide a detailed analysis for an API Data is provided for each

presentation of the API Analyses are presented for Quantity

and Value at the retail purchase level Analyses are presented by

demographic (age) and geographic (parish) distribution

Therapeutic Reports

Provide a detailed analysis for a chosen set of API

Data is provided for each API chosen Analyses are presented for Quantity

and Value at the retail purchase level Analyses are presented by

demographic (age) and geographic (parish) distribution

Market Reports

Provide a detailed analysis for the Illnesses covered by the NHFcard

Data is provided for each Illness Analyses are presented for Quantity

and Value at the retail purchase level Analyses are presented by

demographic (age) and geographic (parish) distribution

Sample ReportNIFEDIPINE NHFcard ACTIVITY JANUARY - JUNE 2008

GEOGRAPHIC ANALYSIS

UNIT SALES (QTY) PATIENT COST (revenue)cap 10mg tabCR 10mg tabCR 20mg tabCR 30mg tabCR 60mg TOTAL CAP 10mg tabCR 10mg tabCR 20mg tabCR 30mg tabCR 60mg TOTAL

CLARENDON 2,352 50,717 114,644 2,749 1,941 172,403 $25,203 $622,543 $1,754,400 $257,252 $273,432 $2,932,830

HANOVER 540 4,147 16,247 0 30 20,964 $7,366 $71,189 $277,189 $0 $4,500 $360,243

KSA 5,549 150,809 427,677 14,762 12,231 611,028 $76,596 $2,325,515 $7,056,163 $1,465,836 $1,781,953 $12,706,064

MANCHESTER 3,740 109,404 212,580 2,377 3,871 331,972 $51,300 $1,415,045 $3,133,534 $224,985 $551,430 $5,376,293

PORTLAND 240 4,065 11,557 203 270 16,335 $3,616 $67,781 $212,403 $21,278 $42,216 $347,294

ST. ANN 4,017 41,617 95,219 1,335 1,182 143,370 $50,043 $646,791 $1,511,990 $128,016 $168,800 $2,505,640

ST. ELIZABETH 390 34,683 87,124 1,646 2,327 126,170 $4,742 $492,677 $1,305,960 $154,521 $329,846 $2,287,745

ST. JAMES 810 53,839 95,090 1,242 1,466 152,447 $10,484 $806,422 $1,427,011 $120,368 $206,143 $2,570,428

ST. MARY 180 15,224 32,280 434 199 48,317 $2,205 $235,464 $445,887 $41,302 $27,546 $752,404

ST.CATHERINE 4,852 84,193 236,499 7,046 3,819 336,409 $72,615 $1,317,484 $4,040,351 $683,813 $555,010 $6,669,272

ST.THOMAS 134 7,901 35,631 678 1,063 45,407 $1,541 $121,568 $528,389 $64,928 $153,930 $870,356

TRELAWNY 0 5,043 11,558 0 30 16,631 $0 $82,166 $203,781 $0 $4,254 $290,202

WESTMORELAND 2,784 20,442 57,826 883 1,163 83,098 $22,960 $284,303 $707,587 $83,141 $161,925 $1,259,917

TOTALS25,588 582,084 1,433,932 33,355 29,592 2,104,551 $328,669 $8,488,948 $22,604,646 $3,245,442 $4,260,984 $38,928,689

1% 28% 68% 2% 1% 1% 22% 58% 8% 11%

DEMOGRAPHIC ANALYSIS

UNIT SALES (QTY) PATIENT COST (revenue)cap 10mg tabCR 10mg tabCR 20mg tabCR 30mg tabCR 60mg TOTAL CAP 10mg tabCR 10mg tabCR 20mg tabCR 30mg tabCR 60mg TOTAL

0-14 174 180 90 0 0 444 $2,228 $2,010 $1,308 $0 $0 $5,546

15-29 204 1,903 5,315 0 42 7,464 $2,097 $26,721 $85,687 $0 $6,136 $120,641

30-44 1,320 38,469 112,735 1,285 1,328 155,137 $18,727 $539,669 $1,840,238 $122,919 $192,628 $2,714,180

45-59 8,241 167,034 540,808 8,998 7,498 732,579 $110,343 $2,404,247 $8,920,190 $865,731 $1,077,352 $13,377,863

60-74 10,173 233,308 506,296 15,297 13,441 778,515 $128,230 $3,398,758 $7,683,047 $1,498,104 $1,933,289 $14,641,427

75-89 5,266 132,914 255,654 6,941 7,142 407,917 $64,333 $1,990,246 $3,882,149 $677,873 $1,032,683 $7,647,284

90+ 210 8,276 13,034 834 141 22,495 $2,712 $127,298 $192,026 $80,815 $18,896 $421,747

Total 25,588 582,084 1,433,932 33,355 29,592 2,104,551 $328,669 $8,488,948 $22,604,646 $3,245,442 $4,260,984 $38,928,689

1% 28% 68% 2% 1% 1% 22% 58% 8% 11%

Sample ChartsUNIT SALES tabCR 60mg

1% cap 10mg

1%

tabCR 30mg

2%

tabCR 20mg

68%

tabCR 10mg

28%

REVENUE - geographic

8%1%

14%6%

6%

7%

2%

17%

2%

3%

1%

1%

32%

CLARENDON

HANOVER

KSA

MANCHESTER

PORTLAND

ST. ANN

ST. ELIZABETH

ST. J AMES

ST. MARY

ST.CATHERINE

ST.THOMAS

TRELAWNY

WESTMORELAND

UNIT SALES - demographic

1%

19%

38%

7%

35%

0%0%

0-14

15-29

30-44

45-59

60-74

75-89

90+

Jamaica Pharmaceutical Market reports are for strategic and

policy decision makers.The reports provide the ability

to undertake a variety of market and product intelligence analyses

Brand Performance Market share analysis

Is the market for your product growing? Is your product maintaining market share? In which parishes are you being

outperformed? Competitive analysis

How are competitive API performing? Are they growing faster than your API? In which parishes are you being

outperformed?

Product Performance

Therapeutic Market analysis Is the market for this Therapeutic

category growing? Is your API maintaining market share? How are competitive API performing? In which parishes are you being

outperformed? Are they growing faster than your API?

Market Performance

Chronic Disease Market analysis What are Jamaican patients spending

their prescription dollar on? What is the market size for a CNCD?

Where is it – parish? Who is it – age? Is there an opportunity to introduce

new products to the Jamaican market?

Competitive Analysis

We have a product not listed with the NHFcard but is used in conjunction with a condition and medications covered by the NHFcard

What is the market for the NHFcard medication with which my product is used

Is my product performing as well as the that medication?

Where - parish

Additional analyses customised for your products can be

prepared and presentations done for management and

marketing retreats/workshops and sales meetings